🇺🇸 [^14C]-LY2835219 in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

[^14C]-LY2835219 ([^14C]-LY2835219) regulatory status in United States.

Marketing authorisation

FDA

Application: ANDA220238
Marketing authorisation holder: QILU PHARMACEUTICAL CO., LTD.
Local brand name: ABEMACICLIB
Indication: TABLET
Status: approved

Read official source →

Frequently asked questions

Is [^14C]-LY2835219 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for [^14C]-LY2835219 in United States?

QILU PHARMACEUTICAL CO., LTD. holds the US marketing authorisation.